The C1q solid phase and Raji cell radioimmune assays were used to determine the frequency of detectable circulating immune complexes in patients with glomerulonephritis. In this study, 46% of 56 patients with glomerulonephritis had evidence of circulating immune complexes. More important, circulating immune complexes were associated with some, but not other, types of glomerulonephritis. Thus, immune complexes were detected in lupus glomerulonephritis (9/9 patients), rapidly progressive glomerulonephritis (5/6 patients), and acute nephritis (5/6 patients), but not in IgA-IgG glomerulonephritis (0/7 patients), or membranous glomerulonephritis (0/8 patients). The Raji cell radioimmune assay and the C1q solid phase radioimmune assay showed concordance of 79% in the detection of circulating immune complexes. Serial determinations, in general, showed either persistence of a negative or positive result of conversion of positive to negative.
INTRODUCTION
Experimental (1) (2) (3) (4) (5) and immunofluorescence studies (6) (7) (8) (9) (10) (11) (12) strongly support the concept that most glomerulonephritis in man is immune complex mediated. Assays to detect circulating immune complexes would This is publication no. 1340 from the Department of Immunopathology, Scripps Clinic and Research Foundation, La Jolla, Calif. Please address reprint requests to Dr. Wilson at this address.
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Received for publication 5 July 1977 and in revised form 6 March 1978. permit objective evaluation of the concept of immune complex-mediated glomerulonephritis, and several such tests have now been reported and recently reviewed (13) . Initial success with assays for circulating immune complexes in systemic immune complex diseases, such as systemic lupus erythematosus (14) (15) (16) , has spurred interest in applying these tests to the study of serum from patients with primary immune complex glomerulonephritis. Immune complexes have been detected in sera from some but not all patients with presumed immune complex glomerulonephritis by the microcomplement consumption test (17, 18) , the platelet aggregation assay (19) , the radiolabeled Clq binding assay (18, (20) (21) (22) (23) , the macrophage uptake assay (24) , the Clq deviation test (25) , the bovine conglutinin assay (26) , and the Raji cell radioimmune assay (*IRCA) (18) . 1 The solid phase Clq assay (ClqSPA) (27) and the *IRCA (28) were employed in the present study to provide quantitative information regarding the frequency of detection of circulating immune complexes in very well-characterized individuals with glomerulonephritis. Both assays are sensitive and IgG specific, but their reactivities are different with the *IRCA detecting immune complex-bound complement components via cell surface complement receptors and the CIqSPA detecting immune complexes which can fix exogenous Clq. These different reactivities were exploited by using the assays in combination.
Renal biopsy
Histologic study of needle or wedge biopsy specimens was done on formalin-fixed, paraffin embedded tissue sections (4 ,um thick) stained with hematoxylin and eosin, periodic acid-Schiff, Jones silver methenamine, and Masson's stains. Immunofluorescence study was done on frozen sections of snap frozen tissue after fixation in an ether:95% ethanol mixture and rinsing in phosphate-buffered saline (PBS) (0.01 M sodium phosphate-buffered 0.15 M NaCl, pH 7.2). Fluorescein isothiocyanate-conjugated antisera to human y-, ,u-, a-, C3-, and fibrin-fibrinogen were used (29) . The sections were viewed with a Leitz Ortholux II UV microscope (E. Leitz, Inc., Rockleigh, N. J.) equipped with the Phloem epi-illuminator. For electron microscopy, small blocks ofrenal cortex were fixed in glutaraldehyde and embedded in Epon.
Ultrathin sections were stained with uranyl acetate and lead citrate and studied with the Hitachi 1 1A electron microscope (Hitachi Ltd., Tokyo, Japan).
Serum samples
Blood for immune complex determinations was allowed to clot at room temperature for 2-3 h and was then centrifuged at 400 g for 20 min at 20°C. Aliquots of sera were stored and shipped at -70°C. The use of aliquots allowed the assays to be performed on previously unthawed serum samples.
Sera from 36 of the 56 patients were obtained within 2 wk of renal biopsy, and 42 were obtained within 2 mo. In 27 patients, follow-up sera (obtained after an interval of 13 to 583 days) were studied for circulating immune complexes, and a third serum sample was studied in 5 of these patients. Sera from 29 healthy laboratory technicians were obtained as normal controls. The sera were studied under double-blind conditions. Quantitation ofcirculating immune complexes *IRCA. The Raji cell radioimmune assay was modified from that described by Theofilopoulos et al., (28) by the addition of radiolabeled bovine serum albumin to correct for nonspecific entrapment. The statistical analysis of the test was also changed by daily comparison to a panel of normal sera, and has recently been described in detail (18) . Results were expressed as micrograms aggregated human gamma globulin (AHG) equivalent per milliliter serum above the mean+±2 SD value of control sera.
The AHG was prepared from human Cohn Fraction II by the method of Mauer et al. (30) , which uses an ultracentrifugation step to remove unaggregated gamma globulin.
Sucrose density gradient fractionation of 1251-labeled AHG showed the aggregates to be 40-100 S. The AHG was stored in aliquots at -70°C and centrifuged at 10,000 g for 5 min before use (18) .
CJqSPA. The method was modified from that described by Hay et al. (27) . Clq was isolated from fresh normal human serum by the method ofYonemasu and Stroud (31) , except that relative salt concentrations of 0.04 M and 0.078 M were used for the first and second precipitation steps, respectively. The purity ofthe isolate was confirmed by immunoelectrophoresis with rabbit antisera to whole human serum and to human C lq. 12 x 75-mm polystyrene tubes (Falcon Plastics, Oxnard, Calif.) were coated with freshly isolated Clq by incubation with approximately 4 gg Clq in 1.0 ml PBS for 20 h at 4°C.
The tubes were then washed three times with 5.0 ml PBS, incubated with 2.0 ml 1% bovine serum albumin in PBS for 2 h at 25°C, washed a further three times with PBS, and then stored at -700C until use. (With the above method, 500-1,000 tubes can be coated with the Clq isolated from 100 ml serum.)
The assay was performed as follows: 50 ,tl test serum was incubated with 100 ul 0.2 M EDTA, pH 7.5, for 30 min at 37°C. 60 ,ul of the EDTA-treated serum was added to Clqcoated tubes in 1.0 ml PBS. Each test was performed in duplicate. The tubes were incubated for 60 min at 37°C and for 20 h at 40C, and were then washed three times with PBS. Approximately 2.5 ,ug 125I-labeled (32) goat antihuman IgG antibody was added in 1.0 ml 1% bovine serum albumin-PBS and incubated for 60 min at 37°C and 30 min at 4°C. The tubes were then washed three times with PBS and radioactivity bound to the tubes was counted in a gamma counter. The result was referred to a standard curve of the binding obtained with AHG in normal human serum and expressed as micrograms AHG equivalent per milliliter serum above the mean+2 SD value of control sera.
Preliminary experiments were performed to evaluate the specificity, sensitivity, and reproducibility of the assay. Thus, the binding obtained with 1-1,000 ,ug AHG per milliliter normal human serum was determined with fresh or heatinactivated (560C for 30 min) Clq-coated tubes and compared with the binding with monomeric IgG ( 1-1,000 Ag 7S human IgG added per milliliter normal human serum). The effect of EDTA treatment of the test serum was assessed by comparing the detection of AHG in fresh normal human serum, heatinactivated (56°C for 30 min) normal human serum, and 0.13 M EDTA treated normal human serum. The influence of certain nonimmune complex reactants was evaluated by testing normal human serum preincubated with heparin (Riker Laboratories, Northridge, Calif) 500 U/ml normal human serum, DNA (Worthington Biochemical Corp., Freehold, N. J.) 100 ,ug/ml normal human serum, or Escherichia coli endotoxin (Difco Laboratories, Detroit, Mich.) 20 ,ug/ml normal human serum. Finally, the stability of Clq-coated tubes with -70°C storage was determined by testing AHG and a panel of six sera on four occasions during a 2-mo period.
Detection of cytotoxic anti-lymphocyte antibody
The patients' sera were tested against a panel of lymphocytes isolated from the peripheral blood of 20 normal individuals. The histocompatibility antigens of the donor lymphocytes were determined to assure that a wide spectrum of antigens was included in the panel. The microcytotoxicity method of Terasaki and McClelland (33) Diagnostic categories (Table I) Group I: Systemic lupus erythematosus (SLE) (patients 1 -9). Eight of the nine patients were female. The other patient (no. 8), a 61-yr-old man, had received procaine amide for cardiac arrhythmia for 4 mo. All patients presented with two or more systemic findings of SLE (malar rash, pleuritis, arthralgia, hemolytic anemia, or Raynaud's syndrome) and were subsequently found to have hematuria and (or) proteinuria. All had strongly positive serum antinuclear antibody and the serum C3 levels (eight patients) were reduced, ranging from 50 to 100 mg/100 ml (normal range = 123-167 mg/100 ml). Four patients (nos. 1-4) had diffuse proliferative glomerulonephritis with subendothelial electron-dense deposits. Three of these patients also had subepithelial dense deposits and two had mesangial deposits. Immunofluorescence studies (two patients) showed granular deposits of immunoglobulins (Ig) and C3 along glomerular capillary loops. Of' the other five patients, four (nos. 5-8) had mesangial proliferative glomerulonephritis with mesangial dense deposits and mesangial deposition of Ig and C3 by immunofluorescence, and one (no. 9) had only minimal glomerular changes with no deposits by electron microscopy or immunofluorescence.
Group I: Antiglomerular basement membrane (GBM) antibody glomerulonephritis (patients 10-12). All patients were teenage females with circulating antiGBM antibodv detectable by radioimmunoassay (13, 34) . The assay employed a radiolabeled extract of'collagenase solubilized human GBM. A double antibody radioimmunoassay was utilized with specific binding >1% considered positive. Two of these patients had linear IgG and C3 deposition along the GBM; one (no. 10) developed severe hemoptysis which was controlled by lung bypass, and the other (no. 11) developed pulmonary infiltrates. The immunofluorescence findings in the third patient were indeterminant because of severe glomerular damage. These patients did not have systemic infections and were not on hemodialysis at the time of' the initial studv for circulating immune complexes. Group) III: Rapidly progressive glomerulonephritis (RPGN) (patients [13] [14] [15] [16] [17] [18] . RPGN was defined as glomerulonephritis in patients wvith rapid deterioration of renal function, negative serum antinuclear antibody, negative antibody to GBM, and the finding of epithelial crescents in over 50% of' the renal glomeruli. Of the patients (four males and two females in this group) two (nos. 13 and 14) had no extrarenal manifestations, tvo (nos. 15 and 16) had skin rash and arthralgia, one (no. 17) had evidence of' recent 8-hemolytic streptococcal pharyngitis, and one (no. 18) had sinusitis and vasculitis. Diagnoses of Henoch-Sch6nlein purpura, poststreptococcal glomerulonephritis, and Wegener's granulomatosis, respectively, were considered in the last four patients but could not be firmly established. Four of the six patienits in this group had glonmerular deposits by electron microscopy and (or) inmmultnofluiorescence consistenit with immuune complexes.
Group) IV: Acute niephritis (patietnts [19] [20] [21] [22] [23] [24] . Of the patients in this grouip (four males and two f'emales), four (nos. [19] [20] [21] [22] had typical acute poststreptococcal glomeruilonlephritis with proven 8-hemolytic streptococcal pharyngitis or skinl inif'ection, hvpertension, hematuria and erythrocyte casts, decreased serumiii C3 levels, increasing or high antistreptolvsin 0 titer, proliferative glomerular changes and granular deposits of Ig and (or) C3, and they recovered with conservative management. The other two patients (nos. 23 and 24) had acute nephritis with diffuse proliferative glomerular changes and granular deposits of C3.
Group V: IgA-IgG disease (patients 25-31). All patients (four males and three females) presented with hematuria. Serum creatinine levels of six patients were below 1.3 mg/100 ml, serum antinuclear antibodies were negative, and serum C3 levels (five patients) were normal in three and slightly reduced in two. Renal biopsy in all patients showed mesangial proliferative changes, intense mesangial deposition of IgA, IgG, and C3, and mesangial electron-dense deposits.
Group VI: Membranous glomerulonephritis (patients 32-39). All patients (six males and two females) presented with heavy proteinuria (range 5-11 g/24 h). Typical subepithelial electron-dense deposits and closely opposed granular IgG along the capillary loops were present in all renal biopsies studied. One patient (no. 37) was in the third trimester of her pregnancy, and two patients (nos. 38 and 39) had renal vein thrombosis.
Group VII: Other glomerulonephritis (patients [40] [41] [42] [43] [44] [45] [46] [47] [48] . In this group were three patients (nos. [40] [41] [42] (35, Case 1) . Electron microscopy in patient 54 showed characteristic amyloid fibrils in the deposits.
RESULTS
In vitro evaluation of the inmune complex assays *lRCA. These studies have already been reported (18, 28) 
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Circulating Immune Complexes in Glomerulonephritis
The assay was not affected by the in vitro addition of heparin, DNA (native or denatured), or E. coli endotoxin to normal human serum. These substances bind Clq and can produce false positive results in the Clq deviation test (38) and the radiolabeled Clq binding assay (18) . The IgG specificity of the ClqSPA is a major advantage in this regard. Unlike the microcomplement consumption test (18, 39) , the ClqSPA appears to be little affected by suboptimal storage and handling conditions of test sera; no alteration in binding was detected after repeated (x 10) 
I000T Studies on patients with glomerulonephritis
Incidence of circulating immune complexes (Table  I ). The overall frequency of detecting circulating immune complexes in initial serum samples from the 56 patients was 46% as determined by both assays. The *IRCA was more frequently positive (38%) than the ClqSPA (32%). In comparison, the *IRCA was positive in 3 and the ClqSPA in none of the 29 control sera.
All nine patients with SLE were positive in one or both assays. The patients with diffuse proliferative lesions and widespread glomerular immune complex deposits (nos. 1-4) had higher levels of circulating immune complexes than patients with immune complex deposits confined to the mesangium (nos. 5-8). Patient 9 without glomerular immune complex deposits was negative in the ClqSPA and only weakly positive in the *IRCA. Follow-up serum immune complex determinations in four patients remained positive in three. The fourth patient (no. 6) had two sera which were weakly positive in the *IRCA, and a third sample which was negative.
Two of the three patients with antiGBM antibody glomerulonephritis were positive in the *IRCA. This is an unusually high frequency of positivity since in previous studies with antiGBM antibody glomerulonephritis, none of 10 (18), and 2 of 26 sera2 were 2 Wilson, C. B. Unpublished observations. (Table I) in general showed either a persistence of a negative or positive result or conversion of positive to negative. However, the number of patients was too small to permit any conclusion regarding the correlation between clinical activity and circulating immune complexes. A relationship between the level of serum C3 and the positivity of the assays for immune complexes appeared to exist (Table I) . Ofthe 27 patients with low C3 levels, 52 and 41% were positive in the *IRCA and the ClqSPA, respectively, compared to 36 and 18% for their normocomplementemic counterparts. In the 17 most severely hypocomplementemic patients (C3 < 100 mg/100 ml), 70 and 53% were positive in the *IRCA and ClqSPA, respectively. When the frequency of positive reactions in this group were compared to that in patients with C3 levels > 100 mg/100 ml, the difference was significant (P < 0.05).
Prevalence of antilymphocyte antibody in glomeruloneplmritis patients. This study wvas included to determine whether antilymphocyte antibody might account for positivity in the *IRCA. Antilymphocyte antibodies Nvere detected in 10 of' the 46 patients tested (22%). The results indicate that antilymphocvte antibo(lies probably did not contribute significantly to *IRCA positivity since, with the exception of SLE, circulating immuine complexes occuirred as fre(uently in the absence as in the presence of antilymphocyte antibodies. In addition, three of the four SLE patients with antilynmphocyte antibodies and high levels of circulating immune complexes by *IRCA were also strongly positive in the ClqSPA.
DISCUSSION
Studies dealing with the detection of circulating immtune complexes in glomerulonephritis are influenced by the type of immune complex assay and by patient selection. In the present study, the *IRCA Circulating Itnmune Comnplexes inl Glonmer-tlonephritis 69 and the ClqSPA with a sensitivity of 5-10 Ag AHG/ml serum were used to test sera from patients with a spectrum of carefully documented forms of glomerulonephritis. It should be noted that the immune complex assays used in this study only detect complexes capable of reacting with complement. Disparity might develop between detection of complexes in the circulation and in renal tissue, because complement fixation may not be prerequisite for deposition of the latter. The assays also preferentially react with large complexes while experimental evidence suggests that complexes ofnear 19 S sedimentation characteristically may be most nephritogenic (41 (42) , and it has been suggested that small immune complexes are responsible for membranous glomerulonephritis (4) . This concept may explain the absence of detectable immune complexes in membranous glomerulonephritis. With the exception of IgA-IgG glomerulonephritis, circulating immune complexes were detected in patients with mesangial deposits which are thought by some to be a result of large immune complexes.
In the chronic serum sickness experimental model of immune complex glomerulonephritis it is clear that the glomerular immune complex deposits are in dynamic equilibrium with immune complexes in the circulation, and that once initiated the disease can be perpetuated by "layering" of free (nonimmune complex) antigen or antihody on to existing binding sites in the glomerular immune complex deposits (13) . More extensive studies with serial immune complex determinations may identify a similar process in human glomerulonephritis. Finally, it is possible that the glomerular immune deposits in some forms of glomerulonephritis in fact represent in situ formed immune complexes. Mauer et al. (43) have described in situ formation of mesangial immune complexes in rats given AHG followed by antibody. Similarly, Izui et al. (44) postulated in situ formation of glomerular DNA-antiDNA immune complexes in mice; in this model, endogenous DNA released into the circulation after administration of bacterial lipopolysaccharide binds to the GBM, where it is readily accessible to antibody. This Arthus-like phenomenon has also been described in experimental thyroiditis (45) , tubulointerstitial nephritis (46) , and postvasectomy orchitis in the rabbit (47, 48 
